Two-stage goal-directed therapy protocol for non-donor open hepatectomy: an interventional before-after study

被引:10
|
作者
Mizunoya, Kazuyuki [1 ]
Fujii, Tomoaki [1 ]
Yamamoto, Masataka [1 ]
Tanaka, Nobuhiro [1 ]
Morimoto, Yuji [1 ]
机构
[1] Hokkaido Univ Hosp, Dept Anesthesiol, Kita Ku, N14,W5, Sapporo, Hokkaido 0608648, Japan
关键词
Hepatectomy; Goal-directed therapy; Stroke volume variation; Central venous pressure; STROKE VOLUME VARIATION; CENTRAL VENOUS-PRESSURE; BLOOD-LOSS; LIVER RESECTION; SURGERY;
D O I
10.1007/s00540-019-02688-4
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Purpose Hemodynamic management during low central venous pressure (L-CVP)-assisted hepatectomy involves fluid restriction during resection and fluid resuscitation after resection. Recently, high stroke volume variation (SVV) has been reported as an alternative to L-CVP for reducing blood loss during a hepatectomy. The current study evaluated the impact of a newly implemented SVV-based goal-directed therapy (GDT) protocol on blood loss during hepatectomy. Methods We conducted a before-after comparative study, which included L-CVP-assisted hepatectomy cases (control group) and GDT-assisted hepatectomy cases (intervention group). The GDT protocol included SVV, cardiac index, and mean arterial pressure as hemodynamic parameters. The target SVV ranges were >= 13% and <= 12% before and after the resection, respectively. The primary endpoint was the proportion of patients whose blood loss was <400 mL (median of our hepatectomy cases) in the GDT group, and it was compared to a predefined threshold of 50%. We also investigated factors associated with blood loss using multiple regression analysis. Results We included 66 patients in the control group and 50 in the GDT group. In the GDT group, the median blood loss was 220 mL and 36 patients (72%) lost <400 mL blood. This was significantly greater than 50% (P<0.001). Post-resection GDT-guided fluid optimization reduced positive intraoperative fluid balance compared to that achieved by the conventional fluid therapy used in the control. Multiple regression analysis showed that GDT application, epidural anesthesia, operative time, and hydroxyethyl-starch infusion volume were associated with blood loss. Conclusion Compared to conventional management, SVV-guided GDT may reduce blood loss during hepatectomies.
引用
收藏
页码:656 / 664
页数:9
相关论文
共 18 条
  • [11] Effects of intraoperative goal-directed fluid therapy and restrictive fluid therapy combined with enhanced recovery after surgery protocol on complications after thoracoscopic lobectomy in high-risk patients: study protocol for a prospective randomized controlled trial
    Guan, Zheng
    Gao, Yanfeng
    Qiao, Qiao
    Wang, Qiang
    Liu, Jingjie
    TRIALS, 2021, 22 (01)
  • [12] One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study
    Puskarich, Michael A.
    Marchick, Michael R.
    Kline, Jeffrey A.
    Steuerwald, Michael T.
    Jones, Alan E.
    CRITICAL CARE, 2009, 13 (05)
  • [13] One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study
    Michael A Puskarich
    Michael R Marchick
    Jeffrey A Kline
    Michael T Steuerwald
    Alan E Jones
    Critical Care, 13
  • [14] Influence of early goal-directed therapy using arterial waveform analysis on major complications after high-risk abdominal surgery: study protocol for a multicenter randomized controlled superiority trial
    Montenij, Leonard
    de Waal, Eric
    Frank, Michael
    van Beest, Paul
    de Wit, Ardine
    Kruitwagen, Cas
    Buhre, Wolfgang
    Scheeren, Thomas
    TRIALS, 2014, 15
  • [15] Influence of early goal-directed therapy using arterial waveform analysis on major complications after high-risk abdominal surgery: study protocol for a multicenter randomized controlled superiority trial
    Leonard Montenij
    Eric de Waal
    Michael Frank
    Paul van Beest
    Ardine de Wit
    Cas Kruitwagen
    Wolfgang Buhre
    Thomas Scheeren
    Trials, 15
  • [16] OCOSO2: study protocol for a single-blinded, multicentre, randomised controlled trial assessing a central venous oxygen saturation-based goal-directed therapy to reduce postoperative complications in high-risk patients after elective major surgery
    Pastene, Bruno
    Bernat, Matthieu
    Baumstark, Karine
    Bezulier, Karine
    Gricourt, Yann
    De Guibert, Jean-Manuel
    Charvet, Aude
    Colin, Manon
    Leone, Marc
    Zieleskiewicz, Laurent
    TRIALS, 2023, 24 (01)
  • [17] OCOSO2: study protocol for a single-blinded, multicentre, randomised controlled trial assessing a central venous oxygen saturation-based goal-directed therapy to reduce postoperative complications in high-risk patients after elective major surgery
    Bruno Pastene
    Matthieu Bernat
    Karine Baumstark
    Karine Bezulier
    Yann Gricourt
    Jean-Manuel De Guibert
    Aude Charvet
    Manon Colin
    Marc Leone
    Laurent Zieleskiewicz
    Trials, 24
  • [18] Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer
    Aokage, Keiju
    Tsuboi, Masahiro
    Zenke, Yoshitaka
    Horinouchi, Hidehito
    Nakamura, Naoki
    Ishikura, Satoshi
    Nishikawa, Hiroyoshi
    Kumagai, Shogo
    Koyama, Shohei
    Kanato, Keisuke
    Kataoka, Tomoko
    Wakabayashi, Masashi
    Fukutani, Miki
    Fukuda, Haruhiko
    Ohe, Yuichiro
    Watanabe, Shun-Ichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (04) : 383 - 387